RT @uptoTate: FUTURE2 analysis of 78 TJC and 76 SJC scores in PsA pts treated with SEC demonstrated improvements in syno
Tweet Content
FUTURE2 analysis of 78 TJC and 76 SJC scores in PsA pts treated with SEC demonstrated improvements in synovitis at Week 24 sustained over 5 years, irrespective of TNFi history & concomitant MTX use. #ABS0875 #ACR20#ACRbest @RheumNow https://t.co/U8B50PTWET https://t.co/fUK1JO10ox
Links
Secukinumab Provides Sustained Improvements in Subgroup Analyses of Joint Tende…
http://ow.ly/U0uH50C9c68
Show on Archive Page
On
Display in Search Results
On